Luminescence imaging in biomedical research has allowed new insights into the
architecture of pathological tissues, signalling networks and cell interactions, and is now …

Background: Biomarker-driven molecular imaging has emerged as an integral part of cancer
precision radiotherapy. The use of molecular imaging probes, including nanoprobes, have …

In vivo imaging technologies have emerged as a powerful tool for both fundamental
research and clinical practice. In particular, luminescence imaging in the tissue-transparent …

Over the past decade, remarkable advances have been witnessed in the development of
small-molecule probes. These molecular tools have been widely applied for interrogating …

External light sources, such as lasers, light emitting diodes (LEDs) and lamps, are widely
applied in photodynamic therapy (PDT); however, their use is severely limited by the nature …

Optical imaging is crucial to study biological or pathological processes and diagnose
diseases. However, poor tissue penetration typically limits conventional optical imaging …

Radioguidance that makes use of β-emitting radionuclides is gaining in popularity and could
have potential to strengthen the range of existing radioguidance techniques. While there is a …

Molecularly generated light, referred to here as “molecular light”, mainly includes
bioluminescence, chemiluminescence, and Cerenkov luminescence. Molecular light …

Recent years, cell-based therapeutics are undergoing explosive growth in the modern
biomedical field. The ability for non-invasively and real-timely tracking and understanding …

Cerenkov radiation (CR) from radionuclides and megavoltage X-ray radiation can act as an
in situ light source for deep cancer theranostics, overcoming the limitations of external light …